EP1287159A4 - Traitement enzymatique des proteines de lactoserum permettant d'obtenir des peptides anti-hypertension, produits obtenus et traitement de l'hypertension chez les mammiferes - Google Patents
Traitement enzymatique des proteines de lactoserum permettant d'obtenir des peptides anti-hypertension, produits obtenus et traitement de l'hypertension chez les mammiferesInfo
- Publication number
- EP1287159A4 EP1287159A4 EP01933181A EP01933181A EP1287159A4 EP 1287159 A4 EP1287159 A4 EP 1287159A4 EP 01933181 A EP01933181 A EP 01933181A EP 01933181 A EP01933181 A EP 01933181A EP 1287159 A4 EP1287159 A4 EP 1287159A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- treatment
- hypertension
- mammals
- production
- resulting products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Vascular Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US702068 | 1991-05-17 | ||
US09/567,283 US6630320B1 (en) | 2000-05-08 | 2000-05-08 | Treatment of hypertension in mammals with hydrolyzed whey proteins |
US567283 | 2000-05-08 | ||
US09/702,068 US6998259B1 (en) | 1999-05-20 | 2000-10-30 | Enzymatic treatment of whey proteins for the production of antihypertensive peptides and the resulting products |
PCT/US2001/014797 WO2001085984A1 (fr) | 2000-05-08 | 2001-05-08 | Traitement enzymatique des proteines de lactoserum permettant d'obtenir des peptides anti-hypertension, produits obtenus et traitement de l'hypertension chez les mammiferes |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1287159A1 EP1287159A1 (fr) | 2003-03-05 |
EP1287159A4 true EP1287159A4 (fr) | 2005-02-09 |
Family
ID=27074429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP01933181A Withdrawn EP1287159A4 (fr) | 2000-05-08 | 2001-05-08 | Traitement enzymatique des proteines de lactoserum permettant d'obtenir des peptides anti-hypertension, produits obtenus et traitement de l'hypertension chez les mammiferes |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1287159A4 (fr) |
JP (1) | JP2004519204A (fr) |
AU (1) | AU2001259625A1 (fr) |
CA (1) | CA2415688A1 (fr) |
MX (1) | MXPA02011018A (fr) |
NZ (1) | NZ523036A (fr) |
WO (1) | WO2001085984A1 (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ508867A (en) | 1998-06-17 | 2003-11-28 | New Zealand Dairy Board | Bioactive whey protein hydrolysate |
EP1517619B1 (fr) | 2002-07-01 | 2007-01-03 | Unilever N.V. | Composition induisant la satiete |
EP1466529A1 (fr) * | 2003-04-07 | 2004-10-13 | Chr. Hansen A/S | Composition destinée à reduire la fréquence cardiaque |
US7718171B2 (en) | 2003-04-07 | 2010-05-18 | Chr. Hansen A/S | Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus |
WO2004098310A1 (fr) * | 2003-05-05 | 2004-11-18 | Unilever N.V. | Peptides ayant un effet inhibiteur sur l'enzyme ace |
ES2253036B1 (es) | 2003-07-31 | 2007-07-16 | Consejo Sup. Investig. Cientificas | Peptidos bioactivos derivados de proteinas de la clara de huevo mediante hidrolisis enzimatica. |
CA2547737A1 (fr) * | 2003-12-15 | 2005-06-30 | Unilever Plc | Peptides presentant un effet inhibiteur de l'eca |
EP1685764A1 (fr) | 2005-01-27 | 2006-08-02 | Globus Egg Sciences B.V. | Produits fonctionnels alimentaires hypotenseurs |
NL1026931C2 (nl) * | 2004-08-31 | 2006-03-01 | Friesland Brands Bv | ACE-remmende wei-hydrolysaten. |
EP1796480B1 (fr) | 2004-09-03 | 2011-11-09 | Chr. Hansen A/S | Lait fermente comprenant un ligand de recepteur et utilisations correspondantes |
FR2876389B1 (fr) * | 2004-10-13 | 2007-05-25 | Viridis Sa | Hydrolysats de proteines blanches de luzerne |
ES2319475B1 (es) | 2005-06-08 | 2010-02-16 | Consejo Superior Investig. Cientificas | Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion. |
DE102008032828A1 (de) | 2008-07-02 | 2010-01-07 | Technische Universität Dresden | Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel |
CN110590916A (zh) | 2013-04-25 | 2019-12-20 | 扬森疫苗与预防公司 | 稳定化的可溶性融合前rsv f多肽 |
WO2017005848A1 (fr) | 2015-07-07 | 2017-01-12 | Janssen Vaccines & Prevention B.V. | Polypeptides f du vrs de pré-fusion solubles stabilisés |
EP3319633B1 (fr) | 2015-07-07 | 2020-11-11 | Janssen Vaccines & Prevention B.V. | Vaccin contre le vrs |
EA201892250A1 (ru) | 2016-04-05 | 2019-03-29 | Янссен Вэксинс Энд Превеншн Б.В. | Вакцина против rsv |
AU2017248021B2 (en) | 2016-04-05 | 2021-08-12 | Janssen Vaccines & Prevention B.V. | Stabilized soluble pre-fusion RSV F proteins |
PL3464331T3 (pl) | 2016-05-30 | 2021-04-19 | Janssen Vaccines & Prevention B.V. | Stabilizowane przedfuzyjne białka F RSV |
CA3061278A1 (fr) | 2017-05-17 | 2018-11-22 | Janssen Vaccines & Prevention B.V. | Procedes et compositions pour induire une immunite protectrice contre l'infection par le vrs |
WO2018210871A1 (fr) | 2017-05-17 | 2018-11-22 | Janssen Vaccines & Prevention B.V. | Procédés et compositions pour induire une immunité protectrice contre l'infection par le vrs |
SG11202001458SA (en) | 2017-09-15 | 2020-03-30 | Janssen Vaccines & Prevention Bv | Method for the safe induction of immunity against rsv |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04282400A (ja) * | 1991-03-12 | 1992-10-07 | Calpis Food Ind Co Ltd:The | アンジオテンシン変換酵素阻害ペプチド組成物 |
JPH06345664A (ja) * | 1993-06-11 | 1994-12-20 | Takako Tomita | 新規な血圧上昇抑制用組成物 |
EP0671126A1 (fr) * | 1992-11-30 | 1995-09-13 | Morinaga Milk Industry Co., Ltd. | Proteine de petit-lait a faible teneur en phosphore, procede de production de ladite proteine, hydrolysat de ladite proteine purifiee et procede de production dudit hydrolysat |
EP0821968A2 (fr) * | 1996-08-02 | 1998-02-04 | The Calpis Food Industry Co., Ltd. | Agent antihypertensif et procédé pour sa préparation |
JPH1033115A (ja) * | 1996-07-24 | 1998-02-10 | Nouchikusangiyou Shinko Jigyodan | ホエー飲料とその製造法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3149199B2 (ja) * | 1991-03-12 | 2001-03-26 | カルピス株式会社 | アンジオテンシン変換酵素阻害ペプチド |
-
2001
- 2001-05-08 AU AU2001259625A patent/AU2001259625A1/en not_active Abandoned
- 2001-05-08 EP EP01933181A patent/EP1287159A4/fr not_active Withdrawn
- 2001-05-08 CA CA002415688A patent/CA2415688A1/fr not_active Abandoned
- 2001-05-08 JP JP2001582572A patent/JP2004519204A/ja active Pending
- 2001-05-08 MX MXPA02011018A patent/MXPA02011018A/es unknown
- 2001-05-08 NZ NZ523036A patent/NZ523036A/en unknown
- 2001-05-08 WO PCT/US2001/014797 patent/WO2001085984A1/fr not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04282400A (ja) * | 1991-03-12 | 1992-10-07 | Calpis Food Ind Co Ltd:The | アンジオテンシン変換酵素阻害ペプチド組成物 |
EP0671126A1 (fr) * | 1992-11-30 | 1995-09-13 | Morinaga Milk Industry Co., Ltd. | Proteine de petit-lait a faible teneur en phosphore, procede de production de ladite proteine, hydrolysat de ladite proteine purifiee et procede de production dudit hydrolysat |
JPH06345664A (ja) * | 1993-06-11 | 1994-12-20 | Takako Tomita | 新規な血圧上昇抑制用組成物 |
JPH1033115A (ja) * | 1996-07-24 | 1998-02-10 | Nouchikusangiyou Shinko Jigyodan | ホエー飲料とその製造法 |
EP0821968A2 (fr) * | 1996-08-02 | 1998-02-04 | The Calpis Food Industry Co., Ltd. | Agent antihypertensif et procédé pour sa préparation |
Non-Patent Citations (7)
Title |
---|
ABUBAKAR A ET AL: "Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion.", JOURNAL OF DAIRY SCIENCE. DEC 1998, vol. 81, no. 12, December 1998 (1998-12-01), pages 3131 - 3138, XP002937027, ISSN: 0022-0302 * |
DATABASE WPI Section Ch Week 199248, Derwent World Patents Index; Class B04, AN 1992-392238, XP002311023 * |
DATABASE WPI Section Ch Week 199510, Derwent World Patents Index; Class B04, AN 1995-070230, XP002311025 * |
DATABASE WPI Section Ch Week 199816, Derwent World Patents Index; Class B04, AN 1998-172040, XP002311024 * |
MULLALLY MARGARET M ET AL: "Angiotensin-I-converting enzyme inhibitory activities of gastric and pancreatic proteinase digests of whey proteins", INTERNATIONAL DAIRY JOURNAL, vol. 7, no. 5, May 1997 (1997-05-01), pages 299 - 303, XP000853725, ISSN: 0958-6946 * |
PIHLANTO-LEPPALA ANNE ET AL: "Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins", INTERNATIONAL DAIRY JOURNAL, vol. 8, no. 4, April 1998 (1998-04-01), pages 325 - 331, XP000853723, ISSN: 0958-6946 * |
See also references of WO0185984A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1287159A1 (fr) | 2003-03-05 |
CA2415688A1 (fr) | 2001-11-15 |
NZ523036A (en) | 2004-04-30 |
WO2001085984A1 (fr) | 2001-11-15 |
AU2001259625A1 (en) | 2001-11-20 |
JP2004519204A (ja) | 2004-07-02 |
MXPA02011018A (es) | 2004-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1287159A4 (fr) | Traitement enzymatique des proteines de lactoserum permettant d'obtenir des peptides anti-hypertension, produits obtenus et traitement de l'hypertension chez les mammiferes | |
HK1048742A1 (en) | Composition comprising casein protein and whey protein. | |
DE69936391D1 (de) | Enterales nahrungsmittel, welches hydrolysiertes sojaprotein und teilweise hydrolysiertes caseinat enthält | |
HUP0203637A3 (en) | Milk protein products and processes | |
HUP0301003A3 (en) | Casein derived peptides and uses thereof in therapy | |
AU3281902A (en) | Methods for the production of multimeric proteins, and related compositions | |
AU2002217505A1 (en) | Process for producing recombinant protein and fused protein | |
AU2864900A (en) | Processes for making protein hydrolysates from animal peptone and for preserving mucosa | |
HUP0500995A3 (en) | Casein derived peptides and uses thereof in therapy | |
PL374192A1 (en) | Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them | |
WO2000017328A3 (fr) | Fibrilles | |
AU2002224555A1 (en) | Process for producing recombinant protein | |
EP1303592A4 (fr) | Nouvelle proteine derivee d'agkistrodon saxatilis emelianov et son procede de preparation | |
AU2001244647A1 (en) | Process for producing recombinant protein | |
HK1052029A1 (en) | Method for increasing the yield of recombinant proteins in microbial fermentation processes. | |
AU2001242750A1 (en) | Novel protein, process for producing the same and use thereof | |
AU2001285109A1 (en) | Microtubule-associated proteins and tubulins | |
ZA200207590B (en) | Production of recombinant blood clotting factors in human cell lines. | |
GB9620144D0 (en) | Process for the production of of glumatic acid and the use of protein hydrolysates in this process | |
EP1174503A4 (fr) | Nouvelles proteines, gene les codant et leur procede d'utilisation | |
EP1111046A4 (fr) | Nouvelle proteine et son procede de production | |
IT1307265B1 (it) | Procedimento per la preparazione di prodotti intermedi nella sintesidi lisinopril. | |
WO2001051011A3 (fr) | Produits de condensation de proteines, a base d'acide azelaique | |
ZA200202526B (en) | Fermentative production of a recombinant protein under limited phosphate concentration. | |
AU2001277707A1 (en) | Promoter, vector and recombinant microorganism having the same and process for producing protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20021206 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61P 9/12 B Ipc: 7C 12Q 1/37 B Ipc: 7C 12Q 1/34 A |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20041228 |
|
18W | Application withdrawn |
Effective date: 20041209 |